Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis ; volume:17 ; number:1 ; day:4 ; month:10 ; year:2022 ; pages:1-7 ; date:12.2022
Addiction science & clinical practice ; 17, Heft 1 (4.10.2022), 1-7, 12.2022
- Creator
-
K. K., Adams
E. J., Miech
D. M., Sobieraj
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-022-00336-z
- URN
-
urn:nbn:de:101:1-2022122409154082896863
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- K. K., Adams
- E. J., Miech
- D. M., Sobieraj
- SpringerLink (Online service)
Other Objects (12)
Single high-dose buprenorphine for opioid craving during withdrawal
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Single high-dose buprenorphine for opioid craving during withdrawal
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Single high-dose buprenorphine for opioid craving during withdrawal
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use